It has also revealed a novel mechanism for how YB-1 selectively functions in regulating the survival of myeloid leukemia cells and indicates a potential therapeutic approach for treating myeloid leukemia, as well as other cancers [85,86,87]. This evidence concerns the gene YBX1 and cancer.